EW
Edwards Lifesciences Corp
3 of the 83 super-investors we track hold EW, worth a combined $377M per their latest 13F filings. The largest position: David Rolfe at 3.1% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 29 of 100 (how strongly the cohort backs it) — ranked #395 of 742 stocks. The stock is up 6.7x since a tracked investor first held it at conviction size (Q1 2014 or earlier). Conviction easing: 1 fewer super-investor hold it than in 2026Q1.
Held through it: David Rolfe (37q straight), Francois Rochon (29q straight), AKO Capital (8q straight) and 3 more. All multibaggers the cohort held →
Why super-investors own EW
EW is held by 3 super-investors in our cohort, with a combined position value of $377M. The highest-conviction owner is David Rolfe at 3.1% of their portfolio. Cohort ownership has shrunk from 4 to 3 over the last four quarters — net interest is fading.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2016Q3 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (3) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | 0.2% | 39q | $362M | 3,997,925 |
| 2 | David Rolfe | 3.1% | 38q | $15M | 165,208 |
| 3 | Torray Funds | <0.1% | 8q | $271K | 2,994 |
Owners of EW also hold
Congress is trading EW
Congress tracker →- Josh Gottheimersold$1,001 - $15,000 · 2025-11-19
- Jefferson Shrevesold$50,001 - $100,000 · 2025-05-12
- Bruce Westermansold$1,001 - $15,000 · 2025-04-21
- Rob Bresnahanbought$1,001 - $15,000 · 2025-04-08
- Jefferson Shrevebought$15,001 - $50,000 · 2025-04-07
- Bruce Westermanbought$1,001 - $15,000 · 2025-03-03
STOCK Act periodic transaction reports; amounts are disclosed ranges. Who files late →
Long US equity 13F-HR filings only. CUSIP 28176E108. Not investment advice.